Shows
Empowered Patient PodcastHow Behavioral Economics is Transforming Healthcare Engagement with Karen Sussman Horgan VAL Health TRANSCRIPT Karen Sussman Horgan is the Co-Founder and CEO of VAL Health, a behavioral economics consulting firm that helps healthcare organizations drive engagement and nudge patients to improve their health and lifestyle choices. Behavioral economics is the science of understanding how patients make irrational choices based on biases, fear, and faulty analysis of outcomes and risk. Nudges can be carrots or sticks, but in healthcare, the focus is on making the right path easier to follow, reducing friction, and introducing positive reinforcements rather than penalties. Karen explains, "We work across the entire healthcare ecosystem. We think about digital...2025-06-0300 minEmpowered Patient PodcastHow Behavioral Economics is Transforming Healthcare Engagement with Karen Sussman Horgan VAL Health Karen Sussman Horgan is the Co-Founder and CEO of VAL Health, a behavioral economics consulting firm that helps healthcare organizations drive engagement and nudge patients to improve their health and lifestyle choices. Behavioral economics is the science of understanding how patients make irrational choices based on biases, fear, and faulty analysis of outcomes and risk. Nudges can be carrots or sticks, but in healthcare, the focus is on making the right path easier to follow, reducing friction, and introducing positive reinforcements rather than penalties. Karen explains, "We work across the entire healthcare ecosystem. We think about digital...2025-06-0319 minEmpowered Patient PodcastDisrupting and Streamlining Traditional Continuous Certification with Karen Schatten National Board of Physicians and Surgeons TRANSCRIPT Karen Schatten, the Associate Director of the National Board of Physicians and Surgeons, is encouraging consideration of alternative paths for continuous certification for board-certified physicians and surgeons. Since 2000, a bureaucratic process has been mandated for this ongoing education. NSPAS aims to modernize and disrupt this process by offering an alternative path for continuing education that addresses physician burnout and provides relevant training to stay current in their medical specialties. Karen explains, "The reason why the bureaucracy persists is, despite it not being really proven and physicians really having to collectively protest it, that requirement we now know af...2024-01-2200 minEmpowered Patient PodcastDisrupting and Streamlining Traditional Continuous Certification with Karen Schatten National Board of Physicians and Surgeons Karen Schatten, the Associate Director of the National Board of Physicians and Surgeons, is encouraging consideration of alternative paths for continuous certification for board-certified physicians and surgeons. Since 2000, a bureaucratic process has been mandated for this ongoing education. NSPAS aims to modernize and disrupt this process by offering an alternative path for continuing education that addresses physician burnout and provides relevant training to stay current in their medical specialties. Karen explains, "The reason why the bureaucracy persists is, despite it not being really proven and physicians really having to collectively protest it, that requirement we now know af...2024-01-2217 min
Empowered Patient PodcastWarning About Potential Risks from Overuse of Acetaminophen with Karen Smith Catie’s Cause TRANSCRIPT Karen Smith is the Founder of Catie's Cause, a nonprofit charity dedicated to building awareness about the safe use of over-the-counter pain medications. After the death of her daughter Catie from liver failure due to overuse of Tylenol, Karen founded this organization to shine a light on the unintended and intentional side effects of easy access to these medicines. Karen explains, "The research shows that there are four main groups of individuals who are impacted by acetaminophen poisoning. Young adults definitely are a large group, oftentimes because they're on their own and they don't realize the dangers o...2023-06-0500 minEmpowered Patient PodcastWarning About Potential Risks from Overuse of Acetaminophen with Karen Smith Catie’s Cause Karen Smith is the Founder of Catie's Cause, a nonprofit charity dedicated to building awareness about the safe use of over-the-counter pain medications. After the death of her daughter Catie from liver failure due to overuse of Tylenol, Karen founded this organization to shine a light on the unintended and intentional side effects of easy access to these medicines. Karen explains, "The research shows that there are four main groups of individuals who are impacted by acetaminophen poisoning. Young adults definitely are a large group, oftentimes because they're on their own and they don't realize the dangers o...2023-06-0517 minEmpowered Patient PodcastIdentifying and Resolving Errors in Healthcare Billing with Michael Axt Zelis TRANSCRIPT Michael Axt, the Chief Member Empowerment Officer at Zelis, is focused on helping healthcare payers and clinicians provide more information to patients about expected costs for procedures and visits to providers and hospitals. A recent survey conducted with Hanover Research revealed insights about patients' challenges in understanding healthcare billing and correcting errors. Driven by the move to transparency, Zelis acquired Sapphire to offer the Sapphire Digital solution to enable patients to better understand insurance benefits and the correct amount the patient owes. Michael explains, "We found some interesting insights. Over 40 percent of the consumers in our study i...2023-04-1300 minEmpowered Patient PodcastIdentifying and Resolving Errors in Healthcare Billing with Michael Axt Zelis Michael Axt, the Chief Member Empowerment Officer at Zelis, is focused on helping healthcare payers and clinicians provide more information to patients about expected costs for procedures and visits to providers and hospitals. A recent survey conducted with Hanover Research revealed insights about patients' challenges in understanding healthcare billing and correcting errors. Driven by the move to transparency, Zelis acquired Sapphire to offer the Sapphire Digital solution to enable patients to better understand insurance benefits and the correct amount the patient owes. Michael explains, "We found some interesting insights. Over 40 percent of the consumers in our study i...2023-04-1318 minEmpowered Patient PodcastHistory of Living with Spinal Muscular Atrophy with Patricia "Pidgie" Panzarino TRANSCRIPT Patricia Panzarino, otherwise known as Pidgie, was born with spinal muscular atrophy, SMA, a severe progressive neuromuscular disease. As a singer and songwriter and one of the oldest women living with SMA, Pidgie is celebrating the release of her new album, Just Breathe. Her experience of successfully taking Evrysdi from Genentech has given her more energy and enthusiasm. Pidgie elaborates, "They didn't know as much when I was born. I was six months old and did not achieve the milestone of crawling properly. My mom took me to the doctor. I had an older sister who had...2023-04-1200 minEmpowered Patient PodcastHistory of Living with Spinal Muscular Atrophy with Patricia "Pidgie" Panzarino Patricia Panzarino, otherwise known as Pidgie, was born with spinal muscular atrophy, SMA, a severe progressive neuromuscular disease. As a singer and songwriter and one of the oldest women living with SMA, Pidgie is celebrating the release of her new album, Just Breathe. Her experience of successfully taking Evrysdi from Genentech has given her more energy and enthusiasm. Pidgie elaborates, "They didn't know as much when I was born. I was six months old and did not achieve the milestone of crawling properly. My mom took me to the doctor. I had an older sister who had...2023-04-1216 minEmpowered Patient PodcastNew Treatments for CTCL a Rare Form of Non-Hodgkin Lymphoma with Dr. Myron Czuczman Citius Pharmaceuticals TRANSCRIPT Dr. Myron Czuczman is the Chief Medical Officer and Executive Vice President of Citius Pharmaceuticals, which is developing an advanced treatment for cutaneous T cell lymphoma, CTCL, a rare form of non-Hodgkin lymphoma. The original version of their drug ONTAK has been reformulated, and I/ONTAK is now in clinical trials to confirm efficacy in controlling severe itching and improving the quality of life for patients. Myron explains, "This is a protein, a fusion protein, of interleukin-2, the whole molecule that has been fused with diphtheria toxin. With respect to any of the cells like the cells...2023-04-1100 minEmpowered Patient PodcastNew Treatments for CTCL a Rare Form of Non-Hodgkin Lymphoma with Dr. Myron Czuczman Citius Pharmaceuticals Dr. Myron Czuczman is the Chief Medical Officer and Executive Vice President of Citius Pharmaceuticals, which is developing an advanced treatment for cutaneous T cell lymphoma, CTCL, a rare form of non-Hodgkin lymphoma. The original version of their drug ONTAK has been reformulated, and I/ONTAK is now in clinical trials to confirm efficacy in controlling severe itching and improving the quality of life for patients. Myron explains, "This is a protein, a fusion protein, of interleukin-2, the whole molecule that has been fused with diphtheria toxin. With respect to any of the cells like the cells...2023-04-1120 minEmpowered Patient PodcastDigital Tool for Parkinson’s Patients Improves Daily Lives with Brian Pepin Rune Labs and Aura Oslapas TRANSCRIPT Brian Pepin is the CEO of Rune Labs, and Aura Oslapas is a woman with Parkinson's who helped create the underlying software for Rune's StrivePD platform. With a focus on precision neurology and a mission to collect relevant data, Rune has refined Aura's work to create an app that allows patients to manage their everyday life better. By combining digital data with logged information, the platform provides a customized plan for each patient to manage unique symptoms. Aura explains, "I've been working in the design world for 40 years. I was someone who, early on in my Parkinson's j...2023-04-1000 minEmpowered Patient PodcastDigital Tool for Parkinson’s Patients Improves Daily Lives with Brian Pepin Rune Labs and Aura Oslapas Brian Pepin is the CEO of Rune Labs, and Aura Oslapas is a woman with Parkinson's who helped create the underlying software for Rune's StrivePD platform. With a focus on precision neurology and a mission to collect relevant data, Rune has refined Aura's work to create an app that allows patients to manage their everyday life better. By combining digital data with logged information, the platform provides a customized plan for each patient to manage unique symptoms. Aura explains, "I've been working in the design world for 40 years. I was someone who, early on in my Parkinson's j...2023-04-1020 minEmpowered Patient PodcastManaging Medical Debt and the Impact of Cost Transparency with Ryne Natzke Sphere TRANSCRIPT Ryne Natzke, Chief Revenue Officer for Sphere, works with healthcare providers to facilitate patient payments using technology to smooth the process. Medical debt is increasing, and reports are that nearly half of Americans can not afford an unexpected $500 medical expense without stress to their budgets. Transparency of costs and adding flexibility to patients for payments are key to reducing the impact of preventative and unexpected medical costs. Ryan explains, "The thing about medical debt also is that it, by definition, is almost always unexpected. You don't plan to go to the emergency room or do anything like th...2023-04-0600 minEmpowered Patient PodcastManaging Medical Debt and the Impact of Cost Transparency with Ryne Natzke Sphere Ryne Natzke, Chief Revenue Officer for Sphere, works with healthcare providers to facilitate patient payments using technology to smooth the process. Medical debt is increasing, and reports are that nearly half of Americans can not afford an unexpected $500 medical expense without stress to their budgets. Transparency of costs and adding flexibility to patients for payments are key to reducing the impact of preventative and unexpected medical costs. Ryan explains, "The thing about medical debt also is that it, by definition, is almost always unexpected. You don't plan to go to the emergency room or do anything like th...2023-04-0618 minEmpowered Patient PodcastPrecision Oncology Using Advanced Biomarkers to Expand Predictive Models with Kat Kwiatkowski Strata Oncology TRANSCRIPT Kat Kwiatkowski, the Senior VP of Clinical Development at Strata Oncology, has tested over 60,000 patients and used their clinical outcome data to build advanced multivariate biomarkers to better predict patient response to approved cancer treatments. Using molecular profiling data, Strata has created an immunotherapy response score leveraging DNA components and the immune gene expression components to better capture the variability and response to PD-L1 therapies. Kat explains, "People with the same cancer, meaning if they have breast or lung cancer, can have different forms of the disease. So responses to treatment can and do vary. Prior to 2012...2023-04-0500 minEmpowered Patient PodcastPrecision Oncology Using Advanced Biomarkers to Expand Predictive Models with Kat Kwiatkowski Strata Oncology Kat Kwiatkowski, the Senior VP of Clinical Development at Strata Oncology, has tested over 60,000 patients and used their clinical outcome data to build advanced multivariate biomarkers to better predict patient response to approved cancer treatments. Using molecular profiling data, Strata has created an immunotherapy response score leveraging DNA components and the immune gene expression components to better capture the variability and response to PD-L1 therapies. Kat explains, "People with the same cancer, meaning if they have breast or lung cancer, can have different forms of the disease. So responses to treatment can and do vary. Prior to 2012...2023-04-0516 minEmpowered Patient PodcastAdvancements in Design and Technology of Pacemakers with Dr. Leonard Ganz Abbott TRANSCRIPT Dr. Leonard Ganz is the Chief Medical Officer and Divisional Vice President of Medical Affairs for Abbott's Cardiac Rhythm Management Division. Traditional pacemakers include a pulse generator that is connected to the inside of the heart with insulated wires. These leads relay the electrical activity that goes between the pacemaker and the heart muscle. The Abbott Aveir VR is a single-chambered leadless pacemaker with improved battery longevity that is implanted inside the heart and eliminates the risks from leads. Len explains, "There are different types of slow heart rhythms that people develop. Most commonly, people develop slow he...2023-04-0400 minEmpowered Patient PodcastAdvancements in Design and Technology of Pacemakers with Dr. Leonard Ganz Abbott Dr. Leonard Ganz is the Chief Medical Officer and Divisional Vice President of Medical Affairs for Abbott's Cardiac Rhythm Management Division. Traditional pacemakers include a pulse generator that is connected to the inside of the heart with insulated wires. These leads relay the electrical activity that goes between the pacemaker and the heart muscle. The Abbott Aveir VR is a single-chambered leadless pacemaker with improved battery longevity that is implanted inside the heart and eliminates the risks from leads. Len explains, "There are different types of slow heart rhythms that people develop. Most commonly, people develop slow he...2023-04-0422 minEmpowered Patient PodcastNext Wave of Virtual Care Platforms Driven by AI Machine Learning and Wearables with Robert Kim Presidio TRANSCRIPT Robert Kim, the Chief Technology Officer at Presidio, works with providers, hospitals, payers, medical device companies, and digital health start-ups to refine and update the telemedicine model. Utilizing wearable and real-time data along with traditional medical data sources, Presidio is creating enterprise virtual care platforms that use artificial intelligence, machine learning, voice recognition, and data analytics to improve productivity and benefit patients, clinicians, and researchers. Rob explains, "One of the things, and the keys to what we're trying to do in utilizing various different AI and ML techniques, is to increase that productivity. So you talk about ge...2023-04-0300 minEmpowered Patient PodcastNext Wave of Virtual Care Platforms Driven by AI Machine Learning and Wearables with Robert Kim Presidio Robert Kim, the Chief Technology Officer at Presidio, works with providers, hospitals, payers, medical device companies, and digital health start-ups to refine and update the telemedicine model. Utilizing wearable and real-time data along with traditional medical data sources, Presidio is creating enterprise virtual care platforms that use artificial intelligence, machine learning, voice recognition, and data analytics to improve productivity and benefit patients, clinicians, and researchers. Rob explains, "One of the things, and the keys to what we're trying to do in utilizing various different AI and ML techniques, is to increase that productivity. So you talk about ge...2023-04-0318 minEmpowered Patient PodcastApplying Acoustic Epidemiology to Determine Significance of the Sound of Coughs with Dr. Peter Small Hyfe AI TRANSCRIPT Dr. Peter Small Chief Medical Officer at Hyfe AI is doing for cough what the thermometer did for fever by allowing people to monitor their cough to identify underlying medical conditions. Using acoustic AI, Hyfe is able to measure cough rates and patterns and identify early warning signs of diseases. Hyfe is leading the way in acoustic epidemiology to better understand the determinants and distribution of disease. Peter explains, "Sound is extremely interesting because AI requires very data-rich signals, and so it's not surprising that in health, the early applications of AI have been in x-ray interpretations...2023-03-2900 minEmpowered Patient PodcastApplying Acoustic Epidemiology to Determine Significance of the Sound of Coughs with Dr. Peter Small Hyfe AI Dr. Peter Small Chief Medical Officer at Hyfe AI is doing for cough what the thermometer did for fever by allowing people to monitor their cough to identify underlying medical conditions. Using acoustic AI, Hyfe is able to measure cough rates and patterns and identify early warning signs of diseases. Hyfe is leading the way in acoustic epidemiology to better understand the determinants and distribution of disease. Peter explains, "Sound is extremely interesting because AI requires very data-rich signals, and so it's not surprising that in health, the early applications of AI have been in x-ray interpretations...2023-03-2918 minEmpowered Patient PodcastDeveloping Naturally Derived Psychedelic Medicines with Benjamin Lightburn Filament Health TRANSCRIPT Benjamin Lightburn, Co-Founder and CEO of Filament Health points out that up until now, research with psychedelics has been done with synthetically prepared psychedelic substances. Filament is making a product through natural extraction that results in a medicine containing psilocybin plus over a dozen other active compounds from the magic mushrooms. This natural process does not require any toxic chemicals and can be distributed through non-medical distribution channels to treat a variety of mental health indications. Benjamin explains, "The psychedelics that have been showing a lot of promise recently in modern well-controlled clinical trials are being used f...2023-03-2800 minEmpowered Patient PodcastDeveloping Naturally Derived Psychedelic Medicines with Benjamin Lightburn Filament Health Benjamin Lightburn, Co-Founder and CEO of Filament Health points out that up until now, research with psychedelics has been done with synthetically prepared psychedelic substances. Filament is making a product through natural extraction that results in a medicine containing psilocybin plus over a dozen other active compounds from the magic mushrooms. This natural process does not require any toxic chemicals and can be distributed through non-medical distribution channels to treat a variety of mental health indications. Benjamin explains, "The psychedelics that have been showing a lot of promise recently in modern well-controlled clinical trials are being used f...2023-03-2818 minEmpowered Patient PodcastTraining Pilots for Challenging Medical Rescue Missions with Melanie Smith Air Methods TRANSCRIPTMelanie Smith, Senior Manager of learning and developing at Air Methods, was a US Army Black Hawk helicopter pilot. She now trains clinicians, emergency medicine experts, pilots, first responders, mechanics, and corporate officials to respond to critical care needs, natural disasters, and accidents. The training program includes hands-on exercises with a high-fidelity manikin that talks back and can throw up, gamification, and virtual reality to provide an immersive experience in different situations. Melanie elaborates, "I flew Black Hawks in the Army for 12 years. Five of those years were spent in combat in Iraq and Afghanistan and earthquake reli...2023-03-2700 minEmpowered Patient PodcastTraining Pilots for Challenging Medical Rescue Missions with Melanie Smith Air MethodsMelanie Smith, Senior Manager of learning and developing at Air Methods, was a US Army Black Hawk helicopter pilot. She now trains clinicians, emergency medicine experts, pilots, first responders, mechanics, and corporate officials to respond to critical care needs, natural disasters, and accidents. The training program includes hands-on exercises with a high-fidelity manikin that talks back and can throw up, gamification, and virtual reality to provide an immersive experience in different situations. Melanie elaborates, "I flew Black Hawks in the Army for 12 years. Five of those years were spent in combat in Iraq and Afghanistan and earthquake reli...2023-03-2716 minEmpowered Patient PodcastProviding Access to Telemedicine and Home Care for Underserved Patients with Dr. Bethany Doran Enabled Health TRANSCRIPT Dr. Bethany Doran, the CEO of Enabled Health, is using a healthcare model that identifies patients at high risk of hospitalization or who need help managing a chronic condition. With a focus on predominantly older patients, Enabled Health works with community partners and senior living facilities to allow patients access to remote monitoring systems, digital tools, and on-site visits. Bethany explains, "Our goal is to meet them where they are spiritually, holistically, and geographically and be able to provide them with the equipment to enable access to telemedicine and support their health. But also, to meet them...2023-03-2200 minEmpowered Patient PodcastProviding Access to Telemedicine and Home Care for Underserved Patients with Dr. Bethany Doran Enabled Health Dr. Bethany Doran, the CEO of Enabled Health, is using a healthcare model that identifies patients at high risk of hospitalization or who need help managing a chronic condition. With a focus on predominantly older patients, Enabled Health works with community partners and senior living facilities to allow patients access to remote monitoring systems, digital tools, and on-site visits. Bethany explains, "Our goal is to meet them where they are spiritually, holistically, and geographically and be able to provide them with the equipment to enable access to telemedicine and support their health. But also, to meet them...2023-03-2218 minEmpowered Patient PodcastBlocking the Root Cause of Chronic Inflammation with David Bearss Halia Therapeutics TRANSCRIPTDavid Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway leads to the activation of this inflammatory response in diseases with components of chronic inflammation, such as Alzheimer's disease, heart disease, COPD, psoriasis, IBD, and cancer. Their potential drug target is the NLRP3 inflammasome which has been identified as being associated with the activation of inflammation. David explains, "We've gotten better and better at trying to narrow down on how we can block th...2023-03-2100 minEmpowered Patient PodcastBlocking the Root Cause of Chronic Inflammation with David Bearss Halia TherapeuticsDavid Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway leads to the activation of this inflammatory response in diseases with components of chronic inflammation, such as Alzheimer's disease, heart disease, COPD, psoriasis, IBD, and cancer. Their potential drug target is the NLRP3 inflammasome which has been identified as being associated with the activation of inflammation. David explains, "We've gotten better and better at trying to narrow down on how we can block th...2023-03-2120 minEmpowered Patient PodcastAutologous Cell Therapies for Solid Tumors Create T Cells Resistant to T Cell Exhaustion with Dr. Tina Albertson Lyell TRANSCRIPTDr. Tina Albertson is the Chief Medical Officer and Head of Development at Lyell, using cell therapy to fight solid tumors through epigenetic and genetic reprogramming methods. Tumors have their own mechanisms for suppressing the immune system. These are the types of pathways Lyell is targeting with their engineering to find ways to counter the exhaustion that the T cells exhibit so that T cells can stay functional and kill the solid tumor cells. Tina explains, "Our cell therapies are from the patient's own cells, so these are what we call autologous cell therapies. We take the c...2023-03-2000 minEmpowered Patient PodcastAutologous Cell Therapies for Solid Tumors Create T Cells Resistant to T Cell Exhaustion with Dr. Tina Albertson LyellDr. Tina Albertson is the Chief Medical Officer and Head of Development at Lyell, using cell therapy to fight solid tumors through epigenetic and genetic reprogramming methods. Tumors have their own mechanisms for suppressing the immune system. These are the types of pathways Lyell is targeting with their engineering to find ways to counter the exhaustion that the T cells exhibit so that T cells can stay functional and kill the solid tumor cells. Tina explains, "Our cell therapies are from the patient's own cells, so these are what we call autologous cell therapies. We take the c...2023-03-2017 minEmpowered Patient PodcastCross-Spectrum Anti-Viral Compounds Needed for Seasonal and Pandemic Infections with Sam Lee Cocrystal Pharma TRANSCRIPTSam Lee is the Co-CEO and President of Cocrystal Pharma, focused on pandemic viruses and seasonal influenza to develop a drug that is cross-spectrum with a high barrier to drug resistance. Using computational data, as well as high-resolution X-ray data, their platform allows options for newly emerging viruses that also address potency and combination treatment options. Sam explains, "We just completed the Phase I study. In the Phase I study, we demonstrated the favorable safety and tolerability of this compound, CC-42344. We designed this compound for pandemic and seasonal influenza A infection. Particularly, this compound is highly...2023-03-1500 minEmpowered Patient PodcastCross-Spectrum Anti-Viral Compounds Needed for Seasonal and Pandemic Infections with Sam Lee Cocrystal PharmaSam Lee is the Co-CEO and President of Cocrystal Pharma, focused on pandemic viruses and seasonal influenza to develop a drug that is cross-spectrum with a high barrier to drug resistance. Using computational data, as well as high-resolution X-ray data, their platform allows options for newly emerging viruses that also address potency and combination treatment options. Sam explains, "We just completed the Phase I study. In the Phase I study, we demonstrated the favorable safety and tolerability of this compound, CC-42344. We designed this compound for pandemic and seasonal influenza A infection. Particularly, this compound is highly...2023-03-1519 minEmpowered Patient PodcastProviding Hybrid Care with Personalized Digital and On-site Musculoskeletal Therapy with Gabriel Mecklenburg Hinge Health TRANSCRIPTGabriel Mecklenburg is the Co-Founder and Executive Chairman at Hinge Health, the leading digital clinic for back, joint, and muscle pain. Hinge provides personalized physical therapy plans by pairing digital and advanced motion-tracking technology with clinical care teams, including doctors, nurses, physical therapists, and board-certified health coaches. Recognizing the value of in-person care, Hinge is rolling out an in-home option to meet the needs of a wide variety of patients. Gabriel explains, "Now, with Hinge Health, it's a digital program, and it's something that you can immediately access from the convenience of your home. You're getting an...2023-03-1400 minEmpowered Patient PodcastProviding Hybrid Care with Personalized Digital and On-site Musculoskeletal Therapy with Gabriel Mecklenburg Hinge HealthGabriel Mecklenburg is the Co-Founder and Executive Chairman at Hinge Health, the leading digital clinic for back, joint, and muscle pain. Hinge provides personalized physical therapy plans by pairing digital and advanced motion-tracking technology with clinical care teams, including doctors, nurses, physical therapists, and board-certified health coaches. Recognizing the value of in-person care, Hinge is rolling out an in-home option to meet the needs of a wide variety of patients. Gabriel explains, "Now, with Hinge Health, it's a digital program, and it's something that you can immediately access from the convenience of your home. You're getting an...2023-03-1419 minEmpowered Patient PodcastT Cell Antigen Coupler Platform Generating Patient-Derived Cell Therapies to Target Solid Tumors with Dr. Paul Lammers Triumvira Immunologics TRANSCRIPT Dr. Paul Lammers, the Chief Executive Officer at Triumvira Immunologics, is developing personalized medicine to treat solid tumors using an autologous approach to arm the patient-derived cells with a vector that identifies and kills individual cancer cells. At the forefront of the next generation of immune-oncology, Triumvira uses the Cocoon Platform made by Lonza to automate this process in a closed system to grow and harvest the cells. The ultimate goal is to have this technology available at the point of care in regional cancer centers to allow this cell therapy to be used by more cancer patients. ...2023-03-1300 minEmpowered Patient PodcastT Cell Antigen Coupler Platform Generating Patient-Derived Cell Therapies to Target Solid Tumors with Dr. Paul Lammers Triumvira Immunologics Dr. Paul Lammers, the Chief Executive Officer at Triumvira Immunologics, is developing personalized medicine to treat solid tumors using an autologous approach to arm the patient-derived cells with a vector that identifies and kills individual cancer cells. At the forefront of the next generation of immune-oncology, Triumvira uses the Cocoon Platform made by Lonza to automate this process in a closed system to grow and harvest the cells. The ultimate goal is to have this technology available at the point of care in regional cancer centers to allow this cell therapy to be used by more cancer patients. ...2023-03-1316 minEmpowered Patient PodcastUsing Clinical Insights from Gait Parameters to Address Fall Risk Physical Therapy and Prosthetics with Tomer Shussman OneStep TRANSCRIPTTomer Shussman, CEO of OneStep, is combining in-person physical therapy and in-person care with remote care to provide more accessible healthcare, improve clinical outcomes, and enable clinicians to generate additional revenue streams. The OneStep smartphone app continuously monitors how patients move and analyzes over 40 different gait parameters. Working with providers, such as physical therapy clinics and orthopedic surgeons, OneStep has entered into the orthotic and prosthetic fields, translating these parameters into actual clinical insights. Tomer explains, "So the main two or three things we've launched in the last year was one, a fall risk model. So we a...2023-03-0800 minEmpowered Patient PodcastUsing Clinical Insights from Gait Parameters to Address Fall Risk Physical Therapy and Prosthetics with Tomer Shussman OneStepTomer Shussman, CEO of OneStep, is combining in-person physical therapy and in-person care with remote care to provide more accessible healthcare, improve clinical outcomes, and enable clinicians to generate additional revenue streams. The OneStep smartphone app continuously monitors how patients move and analyzes over 40 different gait parameters. Working with providers, such as physical therapy clinics and orthopedic surgeons, OneStep has entered into the orthotic and prosthetic fields, translating these parameters into actual clinical insights. Tomer explains, "So the main two or three things we've launched in the last year was one, a fall risk model. So we a...2023-03-0819 minEmpowered Patient PodcastPredicting and Managing Acute Care Demand and Throughput Process with Angie Franks ABOUT Healthcare TRANSCRIPTAngie Franks is the CEO of ABOUT Healthcare, focusing on care orchestration for patients needing acute, post-acute, and transitional care. ABOUT works with healthcare systems to use technology to replace many phone calls and manual work to allow for a smoother process of identifying appropriate and available facilities. This approach also impacts networks of referral sources, making it easier for health systems to build stronger relationships with consistent processes and standards. Angie explains, "When we're talking about a physician seeking the right setting of care for the patient, that process is filled with friction. It's filled with...2023-03-0700 minEmpowered Patient PodcastPredicting and Managing Acute Care Demand and Throughput Process with Angie Franks ABOUT HealthcareAngie Franks is the CEO of ABOUT Healthcare, focusing on care orchestration for patients needing acute, post-acute, and transitional care. ABOUT works with healthcare systems to use technology to replace many phone calls and manual work to allow for a smoother process of identifying appropriate and available facilities. This approach also impacts networks of referral sources, making it easier for health systems to build stronger relationships with consistent processes and standards. Angie explains, "When we're talking about a physician seeking the right setting of care for the patient, that process is filled with friction. It's filled with...2023-03-0717 minEmpowered Patient PodcastTargeting Interactive Pharmaceutical and Healthcare Video Advertising to Patients and Providers with Lauren Ohlsson VDX.tv TRANSCRIPT Lauren Ohlsson is the lead of industry solutions for pharmaceutical and healthcare at VDX.tv, which partners with pharmaceutical marketing teams, healthcare advertisers, and media agencies to create video content that drives engagement with patients and healthcare personnel. They create custom interactive video ad units seen across Connected TVs, desktop computers, and mobile devices and targeted to the desired patients or providers. Using QR codes on CTV and OTT ads allows viewers to scan the code to get additional information quickly. Lauren explains, "One of the specific propositions we add is that we focus on CTV and...2023-03-0600 minEmpowered Patient PodcastTargeting Interactive Pharmaceutical and Healthcare Video Advertising to Patients and Providers with Lauren Ohlsson VDX.tv Lauren Ohlsson is the lead of industry solutions for pharmaceutical and healthcare at VDX.tv, which partners with pharmaceutical marketing teams, healthcare advertisers, and media agencies to create video content that drives engagement with patients and healthcare personnel. They create custom interactive video ad units seen across Connected TVs, desktop computers, and mobile devices and targeted to the desired patients or providers. Using QR codes on CTV and OTT ads allows viewers to scan the code to get additional information quickly. Lauren explains, "One of the specific propositions we add is that we focus on CTV and...2023-03-0617 minEmpowered Patient PodcastDriving Medication Adherence by Redefining the Role of the Pharmacist with Shane Bishop Custom Health TRANSCRIPTShane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine. A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs. Shane elaborates, "Now, where we di...2023-03-0200 minEmpowered Patient PodcastDriving Medication Adherence by Redefining the Role of the Pharmacist with Shane Bishop Custom HealthShane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine. A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs. Shane elaborates, "Now, where we di...2023-03-0218 minEmpowered Patient PodcastNoninvasive Diagnostic Test for Identifying Early-Stage Lung Cancer with Maria Zannes bioAffinity Technologies TRANSCRIPT Maria Zannes, Founder and CEO of bioAffinity Technologies, has developed a noninvasive diagnostic test to screen for early-stage lung cancer. The test uses porphyrin to label cells to find cell populations with cancer cells. Using mucus from the lungs, this is a second test for people who are at high risk, giving them a chance to avoid more invasive procedures to determine their risk level and if they have lung cancer. Maria explains, "The combination of being able to determine that cancer is present in the lungs with our test, coupled with the noninvasive nature of the...2023-03-0100 minEmpowered Patient PodcastNon-invasive Diagnostic Test for Identifying Early-Stage Lung Cancer with Maria Zannes bioAffinity Maria Zannes, Founder and CEO of bioAffinity Technologies, has developed a noninvasive diagnostic test to screen for early-stage lung cancer. The test uses porphyrin to label cells to find cell populations with cancer cells. Using mucus from the lungs, this is a second test for people who are at high risk, giving them a chance to avoid more invasive procedures to determine their risk level and if they have lung cancer. Maria explains, "The combination of being able to determine that cancer is present in the lungs with our test, coupled with the noninvasive nature of the...2023-03-0119 minEmpowered Patient PodcastTreating Acute Agitation with Sublingual Film Formulation with Dr. Rob Risinger BioXcel Therapeutics TRANSCRIPTDr. Robert Risinger is the Chief Medical Officer for Neuroscience at BioXcel Therapeutics, identifying molecules that have off-target indications to address unmet neurological diseases. The initial focus is on acute agitation and the molecules that will address this agitation in patients with bipolar and schizophrenia. Their fast-acting sublingual film formulation is an advancement over the current regime of intramuscular injections. The drug is also being studied for agitation related to Alzheimer's disease and at-home use to reduce the number of people who go to the emergency room for untreated agitation. Rob explains, "For example, the medication, the act...2023-02-2800 minEmpowered Patient PodcastTreating Acute Agitation with Sublingual Film Formulation with Dr. Rob Risinger BioXcel TherapeuticsDr. Robert Risinger is the Chief Medical Officer for Neuroscience at BioXcel Therapeutics, identifying molecules that have off-target indications to address unmet neurological diseases. The initial focus is on acute agitation and the molecules that will address this agitation in patients with bipolar and schizophrenia. Their fast-acting sublingual film formulation is an advancement over the current regime of intramuscular injections. The drug is also being studied for agitation related to Alzheimer's disease and at-home use to reduce the number of people who go to the emergency room for untreated agitation. Rob explains, "For example, the medication, the act...2023-02-2822 minEmpowered Patient PodcastTreating Atopic Dermatitis Using Therapeutic Drug Containing Multiple Bioactive Compounds with Neal Koller Alphyn Biologics TRANSCRIPT Neal Koller is the CEO of Alphyn Biologics, which focuses on improving therapy for skin diseases. Their first topical drug treats both atopic dermatitis and atopic dermatitis with secondary infection. The goal is to treat the recognized immune component of the disease and the bacterial component. Those most affected by this disease are ages 2 to 11 though it is a lifelong recurring problem with only a multi-drug treatment regimen available. Neal explains, "I think we've got three advantages. First, the plant material that we're using is the microbial and small molecule defense liquid of the plant, and so...2023-02-2700 minEmpowered Patient PodcastTreating Atopic Dermatitis Using Therapeutic Drug Containing Multiple Bioactive Compounds with Neal Koller Alphyn Biologics Neal Koller is the CEO of Alphyn Biologics, which focuses on improving therapy for skin diseases. Their first topical drug treats both atopic dermatitis and atopic dermatitis with secondary infection. The goal is to treat the recognized immune component of the disease and the bacterial component. Those most affected by this disease are ages 2 to 11 though it is a lifelong recurring problem with only a multi-drug treatment regimen available. Neal explains, "I think we've got three advantages. First, the plant material that we're using is the microbial and small molecule defense liquid of the plant, and so...2023-02-2716 minEmpowered Patient PodcastLargest COVID Research Database Drives Predictive Modeling of Health Equity and Population Health with Brett Furst HHS Technology Group TRANSCRIPT Brett Furst, President of HHS Technology Group, is carrying on the mission of efforts started at the beginning of the COVID outbreak to collaboratively share data to provide insights to those doing research, drug development, and addressing the impact of the pandemic on vulnerable populations. Maintaining this world's largest COVID database, HTG allows research on complex social determinants of health and how to address health equity. Brett explains, "So we were proud to take it on and be chosen by the consortium. Today we have the largest COVID research database in the world, with over 65 billion records. I...2023-02-2400 minEmpowered Patient PodcastLargest COVID Research Database Drives Predictive Modeling of Health Equity and Population Health with Brett Furst HHS Technology Group Brett Furst, President of HHS Technology Group, is carrying on the mission of efforts started at the beginning of the COVID outbreak to collaboratively share data to provide insights to those doing research, drug development, and addressing the impact of the pandemic on vulnerable populations. Maintaining this world's largest COVID database, HTG allows research on complex social determinants of health and how to address health equity. Brett explains, "So we were proud to take it on and be chosen by the consortium. Today we have the largest COVID research database in the world, with over 65 billion records. I...2023-02-2421 minEmpowered Patient PodcastSlowing the Progression of Rare Polycystic Kidney Disease with Dr. Allen Davidoff XORTX Therapeutics TRANSCRIPT Dr. Allen Davidoff is the Founder and CEO of XORTX Therapeutics, testing the benefit of a therapeutic for autosomal dominant polycystic kidney disease, a rare progressive kidney disease with a clear genetic connection. Evidence suggests that lowering the activity of the xanthine oxidase enzyme in the kidney and lowering uric acid production via this enzyme is critical to developing a therapy that can benefit these patients. Allen explains, "In terms of real therapies that slow the progression of kidney disease, there are very few. And so, to take the example of the rare disease, autosomal dominant polycystic...2023-02-2300 minEmpowered Patient PodcastSlowing the Progression of Rare Polycystic Kidney Disease with Dr. Allen Davidoff XORTX Therapeutics Dr. Allen Davidoff is the Founder and CEO of XORTX Therapeutics, testing the benefit of a therapeutic for autosomal dominant polycystic kidney disease, a rare progressive kidney disease with a clear genetic connection. Evidence suggests that lowering the activity of the xanthine oxidase enzyme in the kidney and lowering uric acid production via this enzyme is critical to developing a therapy that can benefit these patients. Allen explains, "In terms of real therapies that slow the progression of kidney disease, there are very few. And so, to take the example of the rare disease, autosomal dominant polycystic...2023-02-2318 minEmpowered Patient PodcastDeveloping Precision Inhaled Therapy to Treat Pulmonary Arterial Hypertension with Lisa Yanez Aerami Therapeutics TRANSCRIPT Lisa Yanez is the CEO of Aerami Therapeutics, a clinical stage biopharmaceutical company focused on the rare cardiopulmonary disease pulmonary arterial hypertension. Early studies show that using this smart breath-activated inhalation delivery system to administer AER901, inhaled Imatinib reduces side effects and requires less frequent administration by those suffering from PAH. Lisa explains, "Our company is focused on a rare disease, pulmonary arterial hypertension. There was a drug that was an oral drug that was studied before, but due to the side effects, that trial ceased. That said, if you look at the efficacy of that drug...2023-02-2200 minEmpowered Patient PodcastDeveloping Precision Inhaled Therapy to Treat Pulmonary Arterial Hypertension with Lisa Yanez Aerami Therapeutics Lisa Yanez is the CEO of Aerami Therapeutics, a clinical stage biopharmaceutical company focused on the rare cardiopulmonary disease pulmonary arterial hypertension. Early studies show that using this smart breath-activated inhalation delivery system to administer AER901, inhaled Imatinib reduces side effects and requires less frequent administration by those suffering from PAH. Lisa explains, "Our company is focused on a rare disease, pulmonary arterial hypertension. There was a drug that was an oral drug that was studied before, but due to the side effects, that trial ceased. That said, if you look at the efficacy of that drug...2023-02-2216 minEmpowered Patient PodcastCoordinating Patient Participation in Rare Disease Clinical Trials with Scott Gray Clincierge TRANSCRIPTScott Gray is the President and CEO of Clincierge and supporting the activities related to the observation of Rare Disease Day on February 28. Clincierge is focused on coordinating logistical, financial, caregiving, and translation services to facilitate participation in clinical trials by patients with rare diseases. With a personalized, local approach, they support sponsors of research in the recruitment and retention of patients by removing obstacles and reducing stress. Scott explains, "The intent is to provide an energy and a focal point that enables rare disease advocacy work to progress on the local, national, and international levels. The in...2023-02-2100 minEmpowered Patient PodcastCoordinating Patient Participation in Rare Disease Clinical Trials with Scott Gray ClinciergeScott Gray is the President and CEO of Clincierge and supporting the activities related to the observation of Rare Disease Day on February 28. Clincierge is focused on coordinating logistical, financial, caregiving, and translation services to facilitate participation in clinical trials by patients with rare diseases. With a personalized, local approach, they support sponsors of research in the recruitment and retention of patients by removing obstacles and reducing stress. Scott explains, "The intent is to provide an energy and a focal point that enables rare disease advocacy work to progress on the local, national, and international levels. The in...2023-02-2116 minEmpowered Patient PodcastUnlocking the Potential of Genomic Medicine to Treat Autoimmune and Inflammatory Diseases with Sandy Macrae Sangamo Therapeutics TRANSCRIPTSandy Macrae, CEO of Sangamo Therapeutics, talks about the promise and limitations of genomic medicine to find the most effective and affordable treatments for patients with autoimmune and inflammatory diseases. Their CAR-Treg cell therapy platform allows T cells to be tracked throughout the body and activated to release chemicals and signals to reduce inflammation. Small molecule oral pills will always be used to treat diseases and vaccines to prevent them. The goal of genomic medicine is to eradicate the disease. Sandy explains, "We co-opted what's a very natural process and attached a whole series of things to i...2023-02-2000 minEmpowered Patient PodcastUnlocking the Potential of Genomic Medicine to Treat Autoimmune and Inflammatory Diseases with Sandy Macrae Sangamo TherapeuticsSandy Macrae, CEO of Sangamo Therapeutics, talks about the promise and limitations of genomic medicine to find the most effective and affordable treatments for patients with autoimmune and inflammatory diseases. Their CAR-Treg cell therapy platform allows T cells to be tracked throughout the body and activated to release chemicals and signals to reduce inflammation. Small molecule oral pills will always be used to treat diseases and vaccines to prevent them. The goal of genomic medicine is to eradicate the disease. Sandy explains, "We co-opted what's a very natural process and attached a whole series of things to i...2023-02-2016 minEmpowered Patient PodcastAdvanced Sensors Continuously Monitor Extensive Cardiovascular Parameters with Professor Arik Eisenkraft Biobeat TRANSCRIPT Professor Arik Eisenkraft is the VP of Clinical and Regulation at Biobeat, which has developed a short-term disposable chest patch that collects and transmits vital signs data to a cloud-based platform. They have also developed a rechargeable wrist device that collects the same kind of data and is designed for long-term use at home, in care centers, or for clinical trials. Using the optical technique photoplethysmography, they collect reflected light from the tissue not using the light that goes through the tissue, allowing for these form factors. Arik explains, “I can tell you that specifically at Biobeat, we...2023-02-1700 minEmpowered Patient PodcastAdvanced Sensors Continuously Monitor Extensive Cardiovascular Parameters with Professor Arik Eisenkraft Biobeat Professor Arik Eisenkraft is the VP of Clinical and Regulation at Biobeat, which has developed a short-term disposable chest patch that collects and transmits vital signs data to a cloud-based platform. They have also developed a rechargeable wrist device that collects the same kind of data and is designed for long-term use at home, in care centers, or for clinical trials. Using the optical technique photoplethysmography, they collect reflected light from the tissue not using the light that goes through the tissue, allowing for these form factors. Arik explains, “I can tell you that specifically at Biobeat, we...2023-02-1722 minEmpowered Patient PodcastCurating Advanced Diagnostics to Extend Healthspan by Identifying Pre-symptomatic Diseases with Dr. Rakesh Suri Fountain Life TRANSCRIPT Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term value of advanced diagnostics to address individual and population health needs. Rakesh elaborates, "It's leveraging the latest science, shortening the preclinical latency gap between new diagnostic tests, which we know are scientifically impactful. Yet, it takes 10 to 15 years to become embedded in mainstream clinical practice. F...2023-02-1600 minEmpowered Patient PodcastCurating Advanced Diagnostics to Extend Healthspan by Identifying Pre-symptomatic Diseases with Dr. Rakesh Suri Fountain Life Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term value of advanced diagnostics to address individual and population health needs. Rakesh elaborates, "It's leveraging the latest science, shortening the preclinical latency gap between new diagnostic tests, which we know are scientifically impactful. Yet, it takes 10 to 15 years to become embedded in mainstream clinical practice. F...2023-02-1623 minEmpowered Patient PodcastComputational Target Discovery Platform Reveals Insights About Checkpoints and Cancer Immunotherapies with Anat Cohen-Dayag Compugen TRANSCRIPT Anat Cohen-Dayag is the President and CEO of Compugen, which uses its computational discovery platform to identify new drug targets allowing them to develop new treatments based on these new targets. While most immunotherapies are based on proteins PD-1 or PD-L1, Compugen has discovered two other proteins involved in stimulating the immune system response against cancer. Anat elaborates, "In 2009, we discovered the protein called TIGIT. We discovered it computationally, and we sent it to publication back-to-back with Genentech. And this is the protein that is being now developed by Compugen and by others, Genentech being the leader...2023-02-1500 minEmpowered Patient PodcastComputational Target Discovery Platform Reveals Insights About Checkpoints and Cancer Immunotherapies with Anat Cohen-Dayag Compugen Anat Cohen-Dayag is the President and CEO of Compugen, which uses its computational discovery platform to identify new drug targets allowing them to develop new treatments based on these new targets. While most immunotherapies are based on proteins PD-1 or PD-L1, Compugen has discovered two other proteins involved in stimulating the immune system response against cancer. Anat elaborates, "In 2009, we discovered the protein called TIGIT. We discovered it computationally, and we sent it to publication back-to-back with Genentech. And this is the protein that is being now developed by Compugen and by others, Genentech being the leader...2023-02-1522 minEmpowered Patient PodcastBringing Price Certainty and Quality Transparency to Health Insurance Plans with Wally Gomaa SimplePay Health TRANSCRIPT Wally Gomaa, the Co-Founder of SimplePay Health, provides employer-sponsored health insurance plans that bring price certainty to patients. The plan aligns lower costs with higher quality care, giving the individual transparency about the best providers in their community and out-of-pocket cost, which motivates them to choose higher quality care. Wally explains, "If you think about what we're doing, we are simplifying the payment model and the plan design model not only to create a better experience. Health insurance is the most complicated industry on the planet. We're using insurance simplification to naturally self-motivate individuals to choose higher-quality p...2023-02-1400 minEmpowered Patient PodcastBringing Price Certainty and Quality Transparency to Health Insurance Plans with Wally Gomaa SimplePay Health Wally Gomaa, the Co-Founder of SimplePay Health, provides employer-sponsored health insurance plans that bring price certainty to patients. The plan aligns lower costs with higher quality care, giving the individual transparency about the best providers in their community and out-of-pocket cost, which motivates them to choose higher quality care. Wally explains, "If you think about what we're doing, we are simplifying the payment model and the plan design model not only to create a better experience. Health insurance is the most complicated industry on the planet. We're using insurance simplification to naturally self-motivate individuals to choose higher-quality p...2023-02-1418 minEmpowered Patient PodcastChallenges of Diagnosing and Treating Skin Condition Hidradenitis Suppurativa with Dr. Joslyn Kirby HS Foundation TRANSCRIPT Dr. Joslyn Kirby is the President of the HS Foundation, which focuses on improving the lives of those who suffer from Hidradenitis Suppurativa, a skin condition caused by an overactive immune system. Generally people with this condition are misdiagnosed with skin infections and treated with ineffective antibiotics. As a member of the DermTech Scientific Board, Joslyn sees the promise of this non-invasive technology to make a diagnosis for someone with the disease or help make a precise therapeutic selection. Joslyn explains, "This condition is not new. It's just that we've gotten better at giving it a name. I...2023-02-1300 minEmpowered Patient PodcastChallenges of Diagnosing and Treating Skin Condition Hidradenitis Suppurativa with Dr. Joslyn Kirby HS Foundation Dr. Joslyn Kirby is the President of the HS Foundation, which focuses on improving the lives of those who suffer from Hidradenitis Suppurativa, a skin condition caused by an overactive immune system. Generally people with this condition are misdiagnosed with skin infections and treated with ineffective antibiotics. As a member of the DermTech Scientific Board, Joslyn sees the promise of this non-invasive technology to make a diagnosis for someone with the disease or help make a precise therapeutic selection. Joslyn explains, "This condition is not new. It's just that we've gotten better at giving it a name. I...2023-02-1316 minEmpowered Patient PodcastUsing Data Analytics to Develop Effective Health Equity Plans with Shelley Davis Lightbeam Health Solutions TRANSCRIPTShelley Davis, MSN, RNC, CCM, is the VP of Clinical Strategy at Lightbeam Health Solutions expert in moving from the traditional fee-for-service model to a value-based care system. Working alongside providers, Lightbeam is identifying opportunities to provide education and better care to underserved communities with less administrative burden. As part of the ACO Reach model, providers must develop annual health equity plans to identify gaps in access for the most at-risk patients. Shelley explains, "We look at population health management as a way to identify patients, identify members, identify those at the greatest risk to fall through...2023-02-0900 minEmpowered Patient PodcastUsing Data Analytics to Develop Effective Health Equity Plans with Shelley Davis Lightbeam Health SolutionsShelley Davis, MSN, RNC, CCM, is the VP of Clinical Strategy at Lightbeam Health Solutions expert in moving from the traditional fee-for-service model to a value-based care system. Working alongside providers, Lightbeam is identifying opportunities to provide education and better care to underserved communities with less administrative burden. As part of the ACO Reach model, providers must develop annual health equity plans to identify gaps in access for the most at-risk patients. Shelley explains, "We look at population health management as a way to identify patients, identify members, identify those at the greatest risk to fall through...2023-02-0919 minEmpowered Patient PodcastUsing Drug Implants to Reduce Burden of Medication Adherence with Dr. Adam Mendelsohn Vivani Medical TRANSCRIPTDr. Adam Mendelsohn, the CEO of Vivani Medical, seeks to enable people to receive the maximum potential benefits from medicines while minimizing the associated burden with taking those medicines. Drug implants overcome forgetfulness, procrastination, and other human behavior that impacts medication adherence. They anticipate expanding partnerships with various drug molecules and indications around their nano portal drug delivery technology. Adam elaborates, "When these medicines are evaluated in randomized clinical trial settings, they produce fantastic results. But these results don't translate into the real world in the way that they possibly could, and the primary reason for this...2023-02-0800 minEmpowered Patient PodcastUsing Drug Implants to Reduce Burden of Medication Adherence with Dr. Adam Mendelsohn Vivani MedicalDr. Adam Mendelsohn, the CEO of Vivani Medical, seeks to enable people to receive the maximum potential benefits from medicines while minimizing the associated burden with taking those medicines. Drug implants overcome forgetfulness, procrastination, and other human behavior that impacts medication adherence. They anticipate expanding partnerships with various drug molecules and indications around their nano portal drug delivery technology. Adam elaborates, "When these medicines are evaluated in randomized clinical trial settings, they produce fantastic results. But these results don't translate into the real world in the way that they possibly could, and the primary reason for this...2023-02-0817 minEmpowered Patient PodcastTreating Rare Metabolic Muscle Diseases with Dr. Alejandro Dorenbaum Reneo Pharmaceuticals TRANSCRIPTDr. Alejandro Dorenbaum is the Chief Medical Officer of Reneo Pharmaceuticals, developing treatments for primary mitochondrial myopathy, a type of rare metabolic muscle disease. Now with genetic testing, there are special panels devoted to diagnosing PMM that can provide quick results for an accurate diagnosis. Unfortunately, no treatment options are currently available, and physicians only treat the complications. REN001, a drug developed by another pharmaceutical company, is being tested in clinical trials to address muscle strength. Alejandro explains, "The myopathies and, specifically, our lead program is in primary mitochondrial myopathy. Primary mitochondrial myopathies are a group of...2023-02-0700 minEmpowered Patient PodcastTreating Rare Metabolic Muscle Diseases with Dr. Alejandro Dorenbaum Reneo PharmaceuticalsDr. Alejandro Dorenbaum is the Chief Medical Officer of Reneo Pharmaceuticals, developing treatments for primary mitochondrial myopathy, a type of rare metabolic muscle disease. Now with genetic testing, there are special panels devoted to diagnosing PMM that can provide quick results for an accurate diagnosis. Unfortunately, no treatment options are currently available, and physicians only treat the complications. REN001, a drug developed by another pharmaceutical company, is being tested in clinical trials to address muscle strength. Alejandro explains, "The myopathies and, specifically, our lead program is in primary mitochondrial myopathy. Primary mitochondrial myopathies are a group of...2023-02-0717 minEmpowered Patient PodcastUsing Virtual Tools to Extend Access to Orthopedic Care with Bronwyn Spira Force Therapeutics TRANSCRIPTBronwyn Spira, CEO and Co-Founder at Force Therapeutics, allows provider groups, physical therapists, doctors, and nurses to reach out to patients no matter where they are, using virtual tools to expand access to care. Experience during the pandemic demonstrated that patients of all ages are eager to use digital means to address pain and recovery issues on their own time. Virtual orthopedic care also enables providers to be more efficient and helps to address staff shortages and burnout. Bronwyn explains, "Physical therapy that's involved in treating orthopedic conditions is a much healthier way, and a non-opioid dependent...2023-02-0600 minEmpowered Patient PodcastUsing Virtual Tools to Extend Access to Orthopedic Care with Bronwyn Spira Force TherapeuticsBronwyn Spira, CEO and Co-Founder at Force Therapeutics, allows provider groups, physical therapists, doctors, and nurses to reach out to patients no matter where they are, using virtual tools to expand access to care. Experience during the pandemic demonstrated that patients of all ages are eager to use digital means to address pain and recovery issues on their own time. Virtual orthopedic care also enables providers to be more efficient and helps to address staff shortages and burnout. Bronwyn explains, "Physical therapy that's involved in treating orthopedic conditions is a much healthier way, and a non-opioid dependent...2023-02-0618 minEmpowered Patient PodcastUsing Self-Replicating RNA Technology to Treat Telomere Biology Disorders with Akihiro Ko Elixirgen Therapeutics TRANSCRIPTAkihiro Ko is the CEO and Co-Founder of Elixirgen Therapeutics, which was founded with the mission of treating patients using RNA technology. Their c-srRNA, controllable self-replicating RNA, technology is being applied to telomere biology disorders where patients have inherited short telomeres and a failure to develop bone marrow. Elixirgen is looking to restore the ability to create blood cells in patients suffering from this rare disease. Akihiro explains, "We are harnessing the tremendous potential of our controlled self-replicating RNA technology to redefine stem cell therapies for patients using the ZSCAN4 gene. We are working on potentially groundbreaking...2023-02-0200 minEmpowered Patient PodcastUsing Self-Replicating RNA Technology to Treat Telomere Biology Disorders with Akihiro Ko Elixirgen TherapeuticsAkihiro Ko is the CEO and Co-Founder of Elixirgen Therapeutics, which was founded with the mission of treating patients using RNA technology. Their c-srRNA, controllable self-replicating RNA, technology is being applied to telomere biology disorders where patients have inherited short telomeres and a failure to develop bone marrow. Elixirgen is looking to restore the ability to create blood cells in patients suffering from this rare disease. Akihiro explains, "We are harnessing the tremendous potential of our controlled self-replicating RNA technology to redefine stem cell therapies for patients using the ZSCAN4 gene. We are working on potentially groundbreaking...2023-02-0219 minEmpowered Patient PodcastAggregating and Curating Healthcare Data to Address Infectious Diseases and Public Health with Dr. Richard Parker Arcadia TRANSCRIPTRich Parker, MD Chief Medical Officer at Arcadia, is working with large healthcare providers to provide data analytics to address the needs of large populations of patients and very specific groups facing unique challenges. The goal is to get the signal-to-noise ratio correct as quickly as possible to, for example, efficiently develop successful COVID vaccinations and identify which patients need help first in an emergency. More refined stratification of patients is also revealing at-risk patients who may have been missed in earlier analyses of social determinants of health. Rich explains, "So the data comes from so many...2023-02-0100 minEmpowered Patient PodcastAggregating and Curating Healthcare Data to Address Infectious Diseases and Public Health with Dr. Richard Parker ArcadiaRich Parker, MD Chief Medical Officer at Arcadia, is working with large healthcare providers to provide data analytics to address the needs of large populations of patients and very specific groups facing unique challenges. The goal is to get the signal-to-noise ratio correct as quickly as possible to, for example, efficiently develop successful COVID vaccinations and identify which patients need help first in an emergency. More refined stratification of patients is also revealing at-risk patients who may have been missed in earlier analyses of social determinants of health. Rich explains, "So the data comes from so many...2023-02-0118 minEmpowered Patient PodcastDemocratizing Precision Oncology with Tuvik Beker Pangea BiomedTuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with bio-pharma companies on improving the identification of novel targets through better biomarkers, better patient stratification, and combination therapy optimization. Tuvik elaborates, "Rather than looking at the genome and looking for abnormalities in gene coding, those rare fusions, or actionable mutations, what Pangea is doing...2023-01-3118 minEmpowered Patient PodcastDemocratizing Precision Oncology with Tuvik Beker Pangea Biomed TRANSCRIPTTuvik Beker CEO of Pangea Biomed is looking for more accurate biomarkers for oncology to better determine who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with bio-pharma companies on improving the identification of novel targets through better biomarkers, better patient stratification, and combination therapy optimization. Tuvik elaborates, "Rather than looking at the genome and looking for abnormalities in gene coding, those rare fusions, or actionable mutations, what Pangea is doing...2023-01-3100 minEmpowered Patient PodcastDeveloping Fourth-Generation Microbiome Therapies to Treat Autoimmune and Inflammatory Diseases with Dr. Ira Spector SFA Therapeutics TRANSCRIPTDr. Ira Spector is the CEO and Co-Founder of SFA Therapeutics, a clinical stage biopharmaceutical company leading the way as a fourth-generation microbiome company to treat inflammatory and autoimmune diseases. The first microbiome companies focused on fecal transplants, while the next innovation was probiotics. The third generation took the understanding of the bacteria in the GI microbiome to derive bacteria for each patient. SFA is asking what the bacteria make and their physiological function in order to synthetically make those substances as an effective small molecule drug. Ira explains, "The immune system in the human body is...2023-01-3000 minEmpowered Patient PodcastDeveloping Fourth-Generation Microbiome Therapies to Treat Autoimmune and Inflammatory Diseases with Dr. Ira Spector SFA TherapeuticsDr. Ira Spector is the CEO and Co-Founder of SFA Therapeutics, a clinical stage biopharmaceutical company leading the way as a fourth-generation microbiome company to treat inflammatory and autoimmune diseases. The first microbiome companies focused on fecal transplants, while the next innovation was probiotics. The third generation took the understanding of the bacteria in the GI microbiome to derive bacteria for each patient. SFA is asking what the bacteria make and their physiological function in order to synthetically make those substances as an effective small molecule drug. Ira explains, "The immune system in the human body is...2023-01-3018 minEmpowered Patient PodcastInnovation and Developments in Treating Rare Kidney Disease with Dr. Jula Inrig Travere Therapeutics TRANSCRIPTDr. Jula Inrig is the Chief Medical Officer of Travere Therapeutics and is eager to find innovative treatments for rare kidney diseases, which can be challenging to diagnose and have limited therapeutic options. In clinical trials, their lead candidate, sparsentan, reduces proteinuria significantly in patients with IgA Nephropathy and focal segmental glomerulosclerosis (FSGS). Travere is working with the U.S. Preventive Task Force to encourage earlier diagnosis and screening for these often silent diseases. Jula explains, "We've mapped out a path to get therapies approved for trying to avoid really what is one of the most detrimental...2023-01-2700 minEmpowered Patient PodcastInnovation and Developments in Treating Rare Kidney Disease with Dr. Jula Inrig Travere TherapeuticsDr. Jula Inrig is the Chief Medical Officer of Travere Therapeutics and is eager to find innovative treatments for rare kidney diseases, which can be challenging to diagnose and have limited therapeutic options. In clinical trials, their lead candidate, sparsentan, reduces proteinuria significantly in patients with IgA Nephropathy and focal segmental glomerulosclerosis (FSGS). Travere is working with the U.S. Preventive Task Force to encourage earlier diagnosis and screening for these often silent diseases. Jula explains, "We've mapped out a path to get therapies approved for trying to avoid really what is one of the most detrimental...2023-01-2716 minEmpowered Patient PodcastInnovative Treatment to Avoid Kidney Failure from Rare Kidney Diseases with Dr. Jula Inrig Travere Therapeutics TRANSCRIPTDr. Jula Inrig is the Chief Medical Officer of Travere Therapeutics and is eager to find innovative treatments for rare kidney diseases, which can be challenging to diagnose and have limited therapeutic options. In clinical trials, their lead candidate, sparsentan, reduces proteinuria significantly in patients with IgA Nephropathy and focal segmental glomerulosclerosis (FSGS), delaying kidney failure. Travere is working with the U.S. Preventive Task Force to encourage earlier diagnosis and screening for these often silent diseases. Jula explains, "We've mapped out a path to get therapies approved for trying to avoid really what is one of...2023-01-2700 minEmpowered Patient PodcastInnovative Treatment to Avoid Kidney Failure from Rare Kidney Diseases with Dr. Jula Inrig Travere TherapeuticsDr. Jula Inrig is the Chief Medical Officer of Travere Therapeutics and is eager to find innovative treatments for rare kidney diseases, which can be challenging to diagnose and have limited therapeutic options. In clinical trials, their lead candidate, sparsentan, reduces proteinuria significantly in patients with IgA Nephropathy and focal segmental glomerulosclerosis (FSGS), delaying kidney failure. Travere is working with the U.S. Preventive Task Force to encourage earlier diagnosis and screening for these often silent diseases. Jula explains, "We've mapped out a path to get therapies approved for trying to avoid really what is one of...2023-01-2716 minEmpowered Patient PodcastStrategic Advantage of Seamless Access to Virtual Care Workforce and Patient Data with Dr. Lyle Berkowitz KeyCare Medical TRANSCRIPTDr. Lyle Berkowitz, CEO of KeyCare Medical, is listening to consumer feedback and helping health systems provide more virtual care options, particularly for routine types of care. At the same time, KeyCare is working with providers on a strategy that enables them to come up with a plan to care for patients with higher complexity that requires them to be seen in the office. The key to success is the systems integration and data sharing that is possible with this virtual care approach. Lyle explains, "I think virtualists and virtual care technology need to be different in...2023-01-2600 minEmpowered Patient PodcastStrategic Advantage of Seamless Access to Virtual Care Workforce and Patient Data with Dr. Lyle Berkowitz KeyCare MedicalDr. Lyle Berkowitz, CEO of KeyCare Medical, is listening to consumer feedback and helping health systems provide more virtual care options, particularly for routine types of care. At the same time, KeyCare is working with providers on a strategy that enables them to come up with a plan to care for patients with higher complexity that requires them to be seen in the office. The key to success is the systems integration and data sharing that is possible with this virtual care approach. Lyle explains, "I think virtualists and virtual care technology need to be different in...2023-01-2619 minEmpowered Patient PodcastHearing Loss and Expectations for Over-the-Counter Hearing Aids with Dr. Leslie Soiles HearingLife TRANSCRIPTDr. Leslie Soiles is the Chief Audiologist at HearingLife, which provides hearing care through professionals who conduct hearing assessments at physical locations and make recommendations for the appropriate way to treat hearing loss. With advancements in nanotechnology and the availability of over-the-counter hearing aids, there are more opportunities to address hearing loss. Still, there are many issues to be aware of when using those devices. Leslie explains, "Over-the-counter hearing aids are designed for people with mild to moderate hearing loss. Over-the-counter hearing aids don't require a hearing test to be performed, so if somebody thinks that they...2023-01-2500 minEmpowered Patient PodcastHearing Loss and Expectations for Over-the-Counter Hearing Aids with Dr. Leslie Soiles HearingLifeDr. Leslie Soiles is the Chief Audiologist at HearingLife, which provides hearing care through professionals who conduct hearing assessments at physical locations and make recommendations for the appropriate way to treat hearing loss. With advancements in nanotechnology and the availability of over-the-counter hearing aids, there are more opportunities to address hearing loss. Still, there are many issues to be aware of when using those devices. Leslie explains, "Over-the-counter hearing aids are designed for people with mild to moderate hearing loss. Over-the-counter hearing aids don't require a hearing test to be performed, so if somebody thinks that they...2023-01-2519 minEmpowered Patient PodcastPoll Reveals Connection between Physical and Mental and Emotional Pain Diminishes with Age with Dr. Sherry McAllister Foundation for Chiropractic Progress TRANSCRIPTDr. Sherry McAllister is a practicing chiropractor and President of the Foundation for Chiropractic Progress which recently commissioned a Harris Poll about physical and mental health. One of the most concerning findings was that the link between physical and mental pain was strongest in survey participants 35-44 years old. Geographic location was also a factor, as was the sharp difference in how men and women respond to pain. Treating the mind and the body is essential for good health, and F4CP promotes guidelines that emphasize that non-pharmaceutical options for pain treatment should be the first choice, not the...2023-01-2400 minEmpowered Patient PodcastPoll Reveals Connection between Physical and Mental and Emotional Pain Diminishes with Age with Dr. Sherry McAllister Foundation for Chiropractic ProgressDr. Sherry McAllister is a practicing chiropractor and President of the Foundation for Chiropractic Progress which recently commissioned a Harris Poll about physical and mental health. One of the most concerning findings was that the link between physical and mental pain was strongest in survey participants 35-44 years old. Geographic location was also a factor, as was the sharp difference in how men and women respond to pain. Treating the mind and the body is essential for good health, and F4CP promotes guidelines that emphasize that non-pharmaceutical options for pain treatment should be the first choice, not the...2023-01-2419 min